Co-diagnostics, Inc. · NASDAQ:CODX
Durenard Eugene received 1,695 Co-diagnostics, Inc. shares as an award (Form 4)
Traded May 23, 2026 · Filed May 27, 2026
On May 23, 2026, Durenard Eugene (Director) received 1,695 Co-diagnostics, Inc. shares as an award, leaving 10,668 shares. Filed May 27, 2026 (Form 4).
- Awarded
- 1,695 shares
- Holding after
- 10,668 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 23, 2026 | Common Stock | Award | 1,695 | 10,668 | Direct |
Source
Related
- Co-diagnostics, Inc.
- Durenard Eugene
- Co-diagnostics, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Jane Street Group, LLC · Aug 10, 2026
- Schedule 13G · Jane Street Group, LLC · Jun 3, 2026
- Form 4 · Egan Dwight H · May 27, 2026
- Form 4 · Brown Brian Lee · May 27, 2026